Hedge Fund Industry News

A collection of Hedge Fund latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

yahoo.com - Noor Ul Ain Rehman - Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Yahoo!

Pfizer Inc. (NYSE: PFE) is one of the best medical research stocks to buy according to hedge funds. Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S. Food and Drug Administration accepted and granted Priority Review for its supplemental…

businessinsider.com - Huileng Tan - AI may fuel profits at corporate giants and unleash a 'revenge of the dinosaurs,' hedge fund exec says
AI may fuel profits at corporate giants and unleash a 'revenge of the dinosaurs,' hedge fund exec says
Business Insider

Investors are growing jittery about a potential bubble in artificial intelligence stocks, but the real payoff may be just beginning — and it could extend well beyond Silicon Valley's usual winners, a $19 billion hedge fund investor said.

yahoo.com - Noor Ul Ain Rehman - Why is Johnson & Johnson (JNJ) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Why is Johnson & Johnson (JNJ) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Yahoo!

Johnson & Johnson (NYSE: JNJ) is one of the best medical research stocks to buy according to hedge funds. Johnson & Johnson (NYSE:JNJ) announced 12-month pilot-phase data from the OMNY-AF study on February 6 at the 31st Annual AF Symposium in…

yahoo.com - By Nell Mackenzie and Samuel Indyk - Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows
Hedge funds bet big against Hims & Hers Health before Wegovy showdown, Hazeltree data shows
Yahoo!

By Nell Mackenzie and Samuel Indyk LONDON, Feb 13 (Reuters) - Hedge fund bets against Hims & Hers Health hit their highest in at ‌least a year in January, just before the online telehealth ‌firm clashed with Novo Nordisk over its…

u.today - Alex Dovbnya - Major Hong Kong Hedge Fund Reportedly Broke Down During BTC Crash
Major Hong Kong Hedge Fund Reportedly Broke Down During BTC Crash
U.Today

According to a new report from analytics firm 10x Research, market speculation is mounting that a 'multi-billion-dollar Hong Kong hedge fund' has broken down. This has exacerbated the selling pressure that saw Bitcoin plunge from $90,000 to $60,000…

businessinsider.com - Naomi Buchanan - Retail traders piled back into stocks after last week's tech rout. Here's what JPMorgan said they bought.
Retail traders piled back into stocks after last week's tech rout. Here's what JPMorgan said they bought.
Business Insider

Dip-buyers in the retail crowd rushed back into stocks and ETFs after last week's big software-led plunge, JPMorgan says. JPMorgan quantitative strategists examined trading trends among retail investors, finding that retail investors bought the dip…

nytimes.com - Rob Copeland - Goldman Sachs General Counsel Kathryn Ruemmler Resigns Over Epstein Ties
Goldman Sachs General Counsel Kathryn Ruemmler Resigns Over Epstein Ties
The New York Times

Goldman Sachs's top lawyer, Kathryn Ruemmler, resigned on Thursday night in the wake of the Justice Department's release of emails and other material that revealed her extensive relationship with Jeffrey Epstein, the disgraced financier. Ms.

yahoo.com - Soumya Eswaran - What Makes Nike (NKE) an Investment Bet?
What Makes Nike (NKE) an Investment Bet?
Yahoo!

Loomis Sayles, an investment management company, released its “Global Growth Fund” investor letter for the fourth quarter of 2025. A copy of the letter can be downloaded here. The Fund prioritizes investments in high-quality companies…

theguardian.com - Guardian staff reporter - Anthropic raises $30bn in latest round, valuing Claude bot maker at $380bn
Anthropic raises $30bn in latest round, valuing Claude bot maker at $380bn
The Guardian

The artificial intelligence company Anthropic said on Thursday it raised $30bn in its latest funding round that values the Claude maker and OpenAI rival at $380bn, underscoring the breakneck pace of AI investments. The round, led by the Singapore…

yahoo.com - Soumya Eswaran - FPA Queens Road Small Cap Value Fund's New Addition: Eplus (PLUS)
FPA Queens Road Small Cap Value Fund's New Addition: Eplus (PLUS)
Yahoo!

Investment management company First Pacific Advisors recently released its “FPA Queens Road Small Cap Value Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Fund returned -0.36% in Q4 2025…

yahoo.com - Sheryar Siddiq - KeyBanc Raises Monolithic Power Systems (MPWR) Price Target on Record Quarterly Revenue
KeyBanc Raises Monolithic Power Systems (MPWR) Price Target on Record Quarterly Revenue
Yahoo!

Monolithic Power Systems, Inc. (NASDAQ: MPWR) ranks among the best high growth high margin stocks to buy now. On February 6, KeyBanc boosted its price target for Monolithic Power Systems, Inc. (NASDAQ:MPWR) to $1,500 from $1,300, retaining an…

yahoo.com - The Hartford Insurance Group, I (HIG) Stock Forecasts
The Hartford Insurance Group, I (HIG) Stock Forecasts
Yahoo!

Hartford Financial Services Group Inc. is a leading multiline insurance company. The company distributes its insurance products and other financial services through independent agencies. Its shares are a component of the S&P 500. Founded in 1810…

yahoo.com - Sheryar Siddiq - Royal Caribbean (RCL) Named Best-in-Class Cruise Operator by JPMorgan
Royal Caribbean (RCL) Named Best-in-Class Cruise Operator by JPMorgan
Yahoo!

Royal Caribbean Cruises Ltd. (NYSE: RCL) ranks among the best high growth high margin stocks to buy now. On January 29, Royal Caribbean Cruises Ltd. (NYSE:RCL) announced earnings for the fourth quarter of 2025, meeting analyst projections of $2.80…

yahoo.com - Noor Ul Ain Rehman - Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 - Here's Why
Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 - Here's Why
Yahoo!

Biogen Inc. (NASDAQ: BIIB) is one of the best medical research stocks to buy according to hedge funds. On February 10, Wedbush lifted the price target on Biogen Inc. (NASDAQ:BIIB) to $187 from $178, maintaining a Neutral rating on the shares. The…

bloomberg.com - Ye Xie - David Einhorn Bets on Deeper Fed Cuts as One of 'Best Trades'
David Einhorn Bets on Deeper Fed Cuts as One of 'Best Trades'
Bloomberg

Hedge fund manager David Einhorn is betting that the Federal Reserve — under Kevin Warsh — will lower interest rates “substantially more than” markets are currently predicting. The co-founder of Greenlight Capital said…

Receive a Daily briefing on Hedge Fund Industry News

Get Started